DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹2,984 Cr | ₹2,731 Cr | ₹2,156 Cr | ₹1,793 Cr | ₹2,424 Cr |
What is the latest Sundry Debtors ratio of DIVIS LABORATORIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹2,984 Cr |
| Mar2025 | ₹2,731 Cr |
| Mar2024 | ₹2,156 Cr |
| Mar2023 | ₹1,793 Cr |
| Mar2022 | ₹2,424 Cr |
How is Sundry Debtors of DIVIS LABORATORIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,984 Cr | 9.26 | |
| Mar2025 | ₹2,731 Cr | 26.67 | |
| Mar2024 | ₹2,156 Cr | 20.25 | |
| Mar2023 | ₹1,793 Cr | -26.03 | |
| Mar2022 | ₹2,424 Cr | - | |
Compare Sundry Debtors of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹206,930.7 Cr | 6.7% | 18.5% | 12.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,408.0 Cr | 1.8% | 6.8% | 17.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,521.0 Cr | -3.7% | 5.5% | 39.8% | Stock Analytics | |
| CIPLA | ₹119,032.0 Cr | 5.7% | 0.6% | -1.4% | Stock Analytics | |
| MANKIND PHARMA | ₹107,071.0 Cr | 1.4% | 1.8% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.1 Cr | -2% | -15.8% | -8.4% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 6.7% |
18.5% |
12.2% |
| SENSEX | 1.2% |
1.2% |
-5.5% |
You may also like the below Video Courses